Protein fibrillation and nanoparticle interactions: opportunities and challenges (Q38086743)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on April 2013

Language	Label	Description	Also known as
English	Protein fibrillation and nanoparticle interactions: opportunities and challenges	scientific article published on April 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Protein fibrillation and nanoparticle interactions: opportunities and challenges (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

0 references

1 reference

based on heuristic

inferred from title

Morteza Mahmoudi

1

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

author name string

Hamid R Kalhor

2

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Sophie Laurent

3

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

language of work or name

0 references

publication date

1 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

2570-2588

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Protein folding and misfolding

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Alzheimer's amyloid fibrils: structure and assembly

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Amyloid-like features of polyglutamine aggregates and their assembly kinetics

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Effect of nanoparticles on protein folding and fibrillogenesis

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Structural models of amyloid-like fibrils

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Charge substitution shows that repulsive electrostatic interactions impede the oligomerization of Alzheimer amyloid peptides.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Amyloid-beta aggregation

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

A beta oligomers - a decade of discovery

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Intracerebroventricular Administration of Amyloid β-protein Oligomers Selectively Increases Dorsal Hippocampal Dialysate Glutamate Levels in the Awake Rat.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid β protein fibrillation in solution

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

The neurobiology of zinc in health and disease

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Conformational constraints for amyloid fibrillation: the importance of being unfolded

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Disrupting established tumor blood vessels: an emerging therapeutic strategy for cancer.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

The SR-mitochondria interaction: a new player in cardiac pathophysiology.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Regulation and critical role of potassium homeostasis in apoptosis

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Beta-2 microglobulin is an amyloidogenic protein in man.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

The intrachain disulfide bond of beta(2)-microglobulin is not essential for the immunoglobulin fold at neutral pH, but is essential for amyloid fibril formation at acidic pH.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

The repeat domain of the melanosome fibril protein Pmel17 forms the amyloid core promoting melanin synthesis

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

A kinetic model for amyloid formation in the prion diseases: importance of seeding

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Kinetics of aggregation of synthetic beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Light scattering analysis of fibril growth from the amino-terminal fragment beta(1-28) of beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Aggregation and fibrillation of bovine serum albumin

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Requirements for generating sigmoidal time-course aggregation in nucleation-dependent polymerization model

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

The aggregation kinetics of Alzheimer's beta-amyloid peptide is controlled by stochastic nucleation

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

The effect of macromolecular crowding on protein aggregation and amyloid fibril formation

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Secondary nucleation and accessible surface in insulin amyloid fibril formation.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Branching in amyloid fibril growth

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

An analytical solution to the kinetics of breakable filament assembly

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Molecular chaperones: pathways and networks

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Macromolecular crowding: an important but neglected aspect of the intracellular environment

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Effects of macromolecular crowding on protein folding and aggregation

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Natively unfolded proteins: a point where biology waits for physics

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Implications of macromolecular crowding for protein assembly.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Macromolecular crowding accelerates amyloid formation by human apolipoprotein C-II.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

The molecular chaperone, alpha-crystallin, inhibits amyloid formation by apolipoprotein C-II.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

The effects of molecular crowding on the amyloid fibril formation of alpha-lactalbumin and the chaperone action of alpha-casein

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Stepwise dynamics of epitaxially growing single amyloid fibrils

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Direct observation of Abeta amyloid fibril growth and inhibition

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

AFM and STM study of beta-amyloid aggregation on graphite.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Rapid self-assembly of alpha-synuclein observed by in situ atomic force microscopy

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Amyloid-a state in many guises: survival of the fittest fibril fold

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Micro-imaging of amyloid in mice.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Amyloidogenic self-assembly of insulin aggregates probed by high resolution atomic force microscopy

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Amyloid nucleation and hierarchical assembly of Ure2p fibrils. Role of asparagine/glutamine repeat and nonrepeat regions of the prion domains

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

The binding of thioflavin-T to amyloid fibrils: localisation and implications

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Small organic probes as amyloid specific ligands--past and recent molecular scaffolds

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Amyloid oligomers: spectroscopic characterization of amyloidogenic protein states.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Structural study of metastable amyloidogenic protein oligomers by photo-induced cross-linking of unmodified proteins

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Inhibition of amyloid formation by ionic liquids: ionic liquids affecting intermediate oligomers

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Analysis of amyloid aggregates using agarose gel electrophoresis

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Molecular structure of amyloid fibrils: insights from solid-state NMR.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Solid-state NMR as a method to reveal structure and membrane-interaction of amyloidogenic proteins and peptides

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Mechanism of thioflavin T binding to amyloid fibrils.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Optical properties of amyloid stained by Congo red: history and mechanisms

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Methods for staining amyloid in tissues: a review

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Is Congo red an amyloid-specific dye?

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Imaging linear birefringence and dichroism in cerebral amyloid pathologies

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Amyloid associated with elastin-staining laminar aggregates in the lungs of patients diagnosed with acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Computational approaches to fibril structure and formation

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

CHARMM: the biomolecular simulation program

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

GROMACS: fast, flexible, and free

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Simulations as analytical tools to understand protein aggregation and predict amyloid conformation

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Principles governing oligomer formation in amyloidogenic peptides

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

A molecular dynamics approach to the structural characterization of amyloid aggregation.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Effect of beta-sheet propensity on peptide aggregation

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Conformational transition of amyloid beta-peptide

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

A strand-loop-strand structure is a possible intermediate in fibril elongation: long time simulations of amyloid-beta peptide (10-35).

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Emerging ideas on the molecular basis of protein and peptide aggregation

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

What determines the structure and stability of KFFE monomers, dimers, and protofibrils?

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Charge attraction and beta propensity are necessary for amyloid fibril formation from tetrapeptides

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

A possible role for pi-stacking in the self-assembly of amyloid fibrils

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Characterizing amyloid‐beta protein misfolding from molecular dynamics simulations with explicit water

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Directed assembly of block copolymer blends into nonregular device-oriented structures

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Inhibition of the formation of amyloid β-protein fibrils using biocompatible nanogels as artificial chaperones

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Fullerene inhibits beta-amyloid peptide aggregation

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Modulation of gamma-secretase specificity using small molecule allosteric inhibitors

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Structure-activity relationships in peptide modulators of β-amyloid protein aggregation: variation in α,α-disubstitution results in altered aggregate size and morphology

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Loss of autophagy in the central nervous system causes neurodegeneration in mice

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Opposing activities protect against age-onset proteotoxicity

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Synthesis of scyllo-inositol derivatives and their effects on amyloid beta peptide aggregation.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

The molecular mechanisms of the anti-amyloid effects of phenols

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Approaches to discovery and characterization of inhibitors of amyloid beta-peptide polymerization

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Influence of dendrimer's structure on its activity against amyloid fibril formation.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Engineered nanoparticles for biomolecular imaging

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Protein-nanoparticle interactions: opportunities and challenges

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Nanoparticles as catalysts for protein fibrillation

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Nanodiagnostics: a new frontier for clinical laboratory medicine

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

An alternative approach to amyloid fibrils morphology: CdSe/ZnS quantum dots labelled beta-amyloid peptide fragments Abeta (31-35), Abeta (1-40) and Abeta (1-42).

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Inhibition of Amyloid β Protein Fibrillation by Polymeric Nanoparticles

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Chapter 4 - Applications of nanotechnology in molecular imaging of the brain

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Nanotechnological applications for the treatment of neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Nonviral siRNA delivery for gene silencing in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Amyloid-beta associated with chitosan nano-carrier has favorable immunogenicity and permeates the BBB.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Nucleation of protein fibrillation by nanoparticles

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Effect of surface concentration on secondary and tertiary conformational changes of lysozyme adsorbed on silica nanoparticles

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Emerging and potential therapies for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Biomolecular coronas provide the biological identity of nanosized materials

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

The Protein Corona Mediates the Impact of Nanomaterials and Slows Amyloid Beta Fibrillation

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Physiological temperature has a crucial role in amyloid β in the absence and presence of hydrophobic and hydrophilic nanoparticles

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Cell "vision": complementary factor of protein corona in nanotoxicology.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Significance of cell "observer" and protein source in nanobiosciences

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Crucial ignored parameters on nanotoxicology: the importance of toxicity assay modifications and "cell vision"

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Direct conjugation of semiconductor nanocrystals to a globular protein to study protein-folding intermediates.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Synthesis and characterization of fluorinated magnetic core-shell nanoparticles for inhibition of insulin amyloid fibril formation.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

TiO2 nanoparticles promote beta-amyloid fibrillation in vitro.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Quantum dots as ultrasensitive nanoactuators and sensors of amyloid aggregation in live cells

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Inhibition of beta 1-40 amyloid fibrillation with N-acetyl-L-cysteine capped quantum dots

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

PEGylated phospholipid nanomicelles interact with beta-amyloid((1-42)) and mitigate its beta-sheet formation, aggregation and neurotoxicity in vitro

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Inhibition of IAPP and IAPP(20-29) fibrillation by polymeric nanoparticles

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Prefibrillar amyloid aggregates could be generic toxins in higher organisms.

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Stop-and-go kinetics in amyloid fibrillation

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Graphene oxide strongly inhibits amyloid beta fibrillation

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Synthesis, surface architecture and biological response of superparamagnetic iron oxide nanoparticles for application in drug delivery: a review

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Cytotoxicity of Uncoated and Polyvinyl Alcohol Coated Superparamagnetic Iron Oxide Nanoparticles

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Plasma concentration gradient influences the protein corona decoration on nanoparticles

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Thioflavine T interaction with amyloid β-sheet structures

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

In-situ atomic force microscopy study of β-amyloid fibrillization

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Growth of nanowire superlattice structures for nanoscale photonics and electronics

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Equilibrium cluster formation in concentrated protein solutions and colloids

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Identifiers

10.1039/C3NR33193H

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38086743&oldid=2241944711"